FEATURED EDITORIAL
Women’s health remains underdeveloped in drug innovation. Growing momentum across policy, science, and funding creates an opportunity to better align drug discovery with women’s health needs.
- Rats Behind The Wheel: The Right Preclinical Way To Investigate Drug Effects On Driving?
- Biotech Wasn't Ready For AI's Speed; Here's How We Catch Up
- Strained Manufacturing, Complexity Stymie In Vivo Progress
- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
- Is Oncology Precision Medicine Coming of Age?
- CROs In Early Drug Discovery, Part 2: Keeping Pace And Protecting Quality
- The Blue Crayfish: Turning Nature's Efficiency Into Safe, Bioavailable Therapeutics
FEATURED APPLICATION CONTENT
-
Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.
-
Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
Explore how a modular AAV8 platform enables scalable, GMP-ready gene therapy manufacturing with reproducible outcomes, streamlined tech transfer, and adaptability across serotypes.
-
Discover how a CDMO achieved 40x productivity and 15% cost savings by switching to rapid cycling membrane chromatography for ADC polishing, which helped cut process time and buffer use.
-
Continuous biomanufacturing is reshaping how active pharmaceutical ingredients are produced. Learn how modular, automated virus inactivation solutions are helping manufacturers improve efficiency.
-
Explore how digital tools are advancing peptide purification, with a focus on GLP-1 receptor agonists, as well as how process efficiency can be accelerated through real-time insights.
-
Gain insight into how consolidating downstream operations into a single automated system can reduce footprint, cut processing time, and minimize manual errors to help teams work more efficiently.
-
Explore a scalable AAV production platform that improves full capsid yield and dramatically reduces host cell impurities, offering a practical solution to common manufacturing challenges.
-
Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.
-
Process intensification demands smarter orchestration, real-time analytics, and scalable automation. Discover how digital infrastructure enables synchronized, compliant, and predictive biomanufacturing.
-
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
- GO‑4 Drug Combo Offers New Hope for Treating Late-Stage BRCA/PALB2-Mutated Cancers
- From Funding Gaps to AI Frontiers: Insights from the Boston Globe Summit 2025
- Live Insights: 45% Believe The NAMs Industry Should Expand Pre-Competitive Data Sharing Programs
- OpenFold3 Released: Redefining The Limits Of Protein Prediction Models
- Video Spotlight: Where Science Meets Magic with MIT Institute Professor Robert S. Langer
FEATURED NEWS HEADLINES
- Basilea And Phare Bio Enter Partnership Combining Anti-Infectives Industry Expertise With Unique AI Capabilities For The Development Of A Novel Antibiotic
- Chemify Receives An Additional Grant To Accelerate Digital Chemistry Small-Molecule Discovery For Tuberculosis
- Ascletis Announces China National Medical Products Administration Acceptance Of New Drug Application For Denifanstat (ASC40), A First-In-Class FASN Inhibitor For Acne Treatment
- Sagimet's License Partner Ascletis Announced Acceptance Of New Drug Application For Denifanstat For The Treatment Of Moderate To Severe Acne By China's National Medical Products Administration
- Teva Pharmaceuticals Submits New Drug Application To FDA For Olanzapine Extended-Release Injectable Suspension (TEV-'749) For The Once-Monthly Treatment Of Schizophrenia In Adults
- Bora Pharmaceuticals And Corealis Pharma Forge Strategic Alliance To Deliver Seamless, End-To-End Oral Solid Dose Development
- Ocular Therapeutix™ Announces Plans To Accelerate NDA Submission Timeline For AXPAXLI™ In Wet AMD
- Ouro Medicines Receives U.S. FDA Orphan Drug Designation For Gamgertamig (OM336) For Immune Thrombocytopenia
- Agora Open Science Trust Announces Nomination Of M4K2009 As Lead Development Candidate For Pediatric Brain Cancer Therapy
- AI-For-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab For Drug Discovery In Singapore
ARCHIVED NEWSLETTER
- 12.09.25 -- When Preclinical Models Distort The Patient
- 12.01.25 -- Better Outcomes, Faster: PBPK Modeling For Absorption & Solid Form Security
- 12.01.25 -- Better Outcomes, Faster: PBPK Modeling For Absorption & Solid Form Security
- 11.25.25 -- Answering The Call To Develop Novel Drugs For Rare Diseases
- 11.20.25 -- Optimize Formulation And Integrity Workflows